These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6326647)

  • 21. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activities and detection of antigen-antibody complexes.
    Casali P
    Agents Actions Suppl; 1980; 7():10-23. PubMed ID: 7018197
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement receptors.
    Holers VM
    Year Immunol; 1989; 4():231-40. PubMed ID: 2538973
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of human complement by Yersinia enterocolitica: ultrastructural alterations and C3b-deposition.
    Acker G; Brade V
    Zentralbl Bakteriol A; 1980 Nov; 248(2):210-28. PubMed ID: 7223121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophils.
    Krieger JI; Fletcher RC; Siegel SA; Fearon DT; Neblock DS; Boutin RH; Taylor RP; Daddona PE
    J Infect Dis; 1993 Apr; 167(4):865-75. PubMed ID: 8450252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
    Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
    J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.
    Arnaout MA; Dana N; Melamed J; Medicus R; Colten HR
    Immunology; 1983 Feb; 48(2):229-37. PubMed ID: 6822401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte chemotactic factors and the C3b receptor.
    Kay AB; Duncan AJ; Glass EJ; Stewart J
    Kroc Found Ser; 1981; 14():197-211. PubMed ID: 6458667
    [No Abstract]   [Full Text] [Related]  

  • 31. IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.
    Joiner KA; Fries LF; Schmetz MA; Frank MM
    J Exp Med; 1985 Sep; 162(3):877-89. PubMed ID: 3897448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.
    Sahu A; Kozel TR; Pangburn MK
    Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):429-36. PubMed ID: 8092994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.
    Villiers MB; Villiers CL; Jacquier-Sarlin MR; Gabert FM; Journet AM; Colomb MG
    Immunology; 1996 Nov; 89(3):348-55. PubMed ID: 8958046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    Winkelstein JA; Abramovitz AS; Tomasz A
    J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
    [No Abstract]   [Full Text] [Related]  

  • 35. [Progress in the study of complement receptors. Structure and physiologic functions of complement receptors].
    Tamura N
    Nihon Rinsho; 1988 Sep; 46(9):1943-8. PubMed ID: 2977205
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue C3b receptors.
    Schrieber L; Penny R
    Clin Exp Immunol; 1979 Nov; 38(2):316-22. PubMed ID: 527266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new map of glycosaminoglycan and C3b binding sites on factor H.
    Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
    J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity of purified complement component 3b with bovine neutrophils and modulation of complement receptor 1.
    Di Carlo AL; Paape MJ; Miller RH
    Am J Vet Res; 1996 Feb; 57(2):151-6. PubMed ID: 8633799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.